Beacon NewsFlashes – May 14, 2012
Study Reveals Genetic Differences Between MGUS And Multiple Myeloma – In a recent study, Spanish researchers identified chromosomal abnormalities that were more frequent in patients with active mutiple...
View ArticleBeacon NewsFlashes – May 30, 2012
INNO-206 Shows Activity Against Myeloma – Results of a preclinical study show that the investigational drug INNO-206 inhibits blood vessel formation and reduces cell growth in myeloma cell lines. The...
View ArticleASCO 2012 Multiple Myeloma Update – Day Four: Poster Presentations On Various...
Today is the last day of this year’s American Society of Clinical Oncology (ASCO) annual meeting, which is being held in Chicago. However, the multiple myeloma-related presentations at the meeting...
View ArticlePersonal Perspective: Former Nurse Battles MGUS And Other Immune Disorders...
Brenda Driver, a 59-year old former nurse from California, was diagnosed with monoclonal gammopathy of undetermined significance (MGUS) in August last year. She took the diagnosis as a blessing in...
View ArticleASH 2012 Multiple Myeloma Update – Day One: Poster Sessions
Yesterday was the first day of research presentations at this year’s American Society of Hematology (ASH) annual meeting, which is being held in Atlanta. Research findings related to multiple myeloma...
View ArticleBeacon NewsFlashes – February 11, 2013
FDA Approves Generic Doxil – The FDA recently approved a generic version of Doxil (doxorubicin liposomal), a drug used to treat several different cancers, including multiple myeloma. Doxil was in...
View ArticleA Look At The Myeloma-Related Poster Presentations At The EHA Congress (EHA...
This year’s Congress of the European Hematology Association (EHA) is currently being held in Stockholm. It started earlier this week and will run through Sunday, June 16. A substantial amount of...
View ArticleResearchers Develop Model To Identify Myeloma Patients With MGUS-Like Disease
Spanish researchers recently developed a new model based on a technique called multiparameter flow cytometry that can identify newly diagnosed multiple myeloma patients with disease profiles similar to...
View ArticleResearchers Investigate Genetic Changes That Drive The Progression Of Myeloma
Findings from a recent study conducted by a group of European researchers show that genetically diverse abnormal plasma cells, known as clones, are present in all stages of myeloma, from its...
View ArticleWhole-Body MRI Helps Identify MGUS Patients At Risk For Progression To...
Findings from a German retrospective study indicate that whole-body magnetic resonance imaging can help identify patients with monoclonal gammopathy of undetermined significance who are at increased...
View Article
